| HOME >> BIOLOGY >> TECHNOLOGY |
(1) Calculated by dividing EBITDASO from above by weighted average shares outstanding, as reported below.
Conference Call
United Therapeutics will host a half-hour teleconference on Tuesday, February 19, 2008, at 9:00 a.m. Eastern Time. The teleconference is accessible by dialing 1-800-603-1777, with international callers dialing 1- 706-679-8129. A rebroadcast of the teleconference will be available for one week by dialing 1-800-642-1687, with international callers dialing 1-706-645- 1687, and using access code 33422885.
This teleconference is also being webcast and can be accessed via United Therapeutics' website at http://ir.unither.com/eventdetail.cfm?eventid=51056.
About United Therapeutics
United Therapeutics Corporation is a biotechnology company focused on the development and commercialization of unique products to address the unmet medical needs of patients with chronic and life-threatening cardiovascular and infectious diseases and cancer.
Non-GAAP Financial Information
This press release contains certain financial measures that do not comply with GAAP, which measures supplement our financial results prepared in accordance with GAAP.
We use EBITDASO, a non-GAAP measure, for our operating, budgeting and financial planning purposes and as a metric for our Company-wide Milestone Incentive Bonus Program, and believe our investors' understanding of our performance is enhanced by disclosing this measure.
The presentation of these non-GAAP financial measures is not to be considered in isolation or as a substitute for our financial results prepared in accordance with GAAP.
Forward-looking Statements
Statements included in this press release that are not historical in
nature are "forward-looking statements" within the meaning of the Private
Securities Reform Act of 1995. These forward-looking st
'/>"/>
| SOURCE United Therapeutics Corporation Copyright©2008 PR Newswire. All rights reserved |